After 400% Surge, Should Investors Care About Monte Rosa Insider Sale?
A biotech stock sprinted 400% in a year, and an insider sale worth about $882k followed. The question for investors: ...
Identify the ideal low-cost index funds for retirement using transparent criteria and performance benchmarks to guide your choices.
27,007 articlesA biotech stock sprinted 400% in a year, and an insider sale worth about $882k followed. The question for investors: ...
An upbeat analyst stance helped lift shares of the first watch restaurant group. This article breaks down the catalys...
XRP surged above key resistance as volume inflows and ETF demand point to renewed institutional interest. Regulators ...
XRP Ledger's latest upgrade crosses a key validator threshold, reinforcing network stability while XRP trades in a ti...
July 16 could be a pivotal date for Nvidia and the broader AI chip ecosystem. This guide explains why Nvidia investor...
Aehr Test Systems faces a pivotal Q4 print after the market closes, with AI burn-in demand and bookings in focus as t...
Kalshi has halted plans to list flight-cancellation contracts as social media debates and data-use hurdles rise, sign...
Apple files a federal trade secret suit against OpenAI, arguing a pattern of theft to protect its hardware lead. The ...
Occidental Petroleum surged after announcing a $5.8 billion debt reduction tied to the OxyChem sale and an uptick in ...
Bitcoin traders are pricing a sharp pullback, with Polymarket data signaling a 75% chance BTC falls below 55,000 as m...
A Pentagon deadline to Anthropic places AI safeguards at the center of a national-security debate, threatening major ...
A volatile week looms for crypto as macro headlines, geopolitics, and policy signals converge. Here are the five thin...